Supply chain resilience has become top of mind for medical professionals and device manufacturers.

The pharmaceutical sector has come under ever-greater scrutiny in recent years, as more and more counterfeit products infiltrate legitimate supply chains.

Life sciences companies need to draw on the tools and protections in their supplier contracts to maintain continuity and minimize disruption.

The importation of fake and fraudulent medical supplies must be stopped.

What lessons did the healthcare supply chain learn from the COVID-19 pandemic? 

The prescription for getting well lies in a true partnership between healthcare logistics and the supply chain.

A little-known federal agency in charge of stockpiling vaccines and mobilizing supplies in health emergencies is being reorganized to apply lessons learned in the Covid pandemic.

Biogen Inc.’s new chief executive officer outlined some of his first steps toward his vision for the biotechnology company with plans to boost investment in new drugs the company is developing for Alzheimer’s disease, lupus and other illnesses.